Halozyme Therapeutics, Inc. (HALO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 376.71M | 451.77M | 354.26M | 325.72M | 264.86M | 298.01M | 290.08M | 231.35M | 195.88M | 230.04M | 216.03M | 221.04M |
| Revenue Growth % | 42.23% | 51.6% | 22.12% | 40.79% | 35.22% | 29.55% | 34.28% | 4.67% | 20.81% | 26.75% | 3.38% | 45.07% |
| Cost of Goods Sold | 108.75M | 102.15M | 73M | 64.12M | 66.17M | 42.05M | 49.43M | 57.37M | 46.09M | 52.3M | 54.82M | 50.07M |
| COGS % of Revenue | 28.87% | 22.61% | 20.61% | 19.69% | 24.98% | 14.11% | 17.04% | 24.8% | 23.53% | 22.73% | 25.38% | 22.65% |
| Gross Profit | 267.96M | 349.62M | 281.26M | 261.6M | 198.7M | 255.95M | 240.66M | 173.98M | 149.79M | 177.74M | 161.21M | 170.97M |
| Gross Margin % | 71.13% | 77.39% | 79.39% | 80.31% | 75.02% | 85.89% | 82.96% | 75.2% | 76.47% | 77.27% | 74.62% | 77.35% |
| Gross Profit Growth % | 34.86% | 36.6% | 16.87% | 50.36% | 32.65% | 44% | 49.28% | 1.76% | 17.97% | 27.53% | -0.28% | 44.37% |
| Operating Expenses | 83.44M | 95.22M | 63.34M | 59.16M | 57.16M | 80.45M | 77.46M | 56.75M | 54.24M | 76.71M | 72.93M | 76.51M |
| OpEx % of Revenue | 22.15% | 21.08% | 17.88% | 18.16% | 21.58% | 27% | 26.7% | 24.53% | 27.69% | 33.34% | 33.76% | 34.61% |
| Selling, General & Admin | 57.88M | 63.33M | 46.09M | 41.61M | 42.36M | 42.25M | 41.24M | 35.71M | 35.13M | 37.61M | 35.27M | 38.95M |
| SG&A % of Revenue | 15.37% | 14.02% | 13.01% | 12.78% | 15.99% | 14.18% | 14.22% | 15.44% | 17.94% | 16.35% | 16.33% | 17.62% |
| Research & Development | 25.56M | 31.9M | 17.25M | 17.54M | 14.8M | 20.44M | 18.46M | 21.04M | 19.11M | 21.34M | 17.32M | 19.73M |
| R&D % of Revenue | 6.79% | 7.06% | 4.87% | 5.39% | 5.59% | 6.86% | 6.36% | 9.09% | 9.76% | 9.27% | 8.02% | 8.92% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 1000K |
| Operating Income | 184.52M | 254.4M | 217.92M | 202.44M | 141.53M | 175.5M | 163.2M | 117.23M | 95.54M | 101.03M | 88.28M | 94.46M |
| Operating Margin % | 48.98% | 56.31% | 61.51% | 62.15% | 53.44% | 58.89% | 56.26% | 50.67% | 48.78% | 43.92% | 40.86% | 42.73% |
| Operating Income Growth % | 30.37% | 44.95% | 33.53% | 72.68% | 48.14% | 73.7% | 84.86% | 24.11% | 77.58% | 35.6% | 5.99% | 177.33% |
| EBITDA | 218.25M | 281.08M | 238.38M | 222.9M | 161.98M | 195.92M | 183.56M | 137.6M | 115.75M | 121.73M | 111.32M | 115.09M |
| EBITDA Margin % | 57.94% | 62.22% | 67.29% | 68.43% | 61.16% | 65.74% | 63.28% | 59.47% | 59.09% | 52.92% | 51.53% | 52.07% |
| EBITDA Growth % | 34.74% | 43.47% | 29.87% | 62% | 39.95% | 60.95% | 64.89% | 19.55% | 55.87% | 49.13% | -1.04% | 147.18% |
| D&A (Non-Cash Add-back) | 33.73M | 26.68M | 20.46M | 20.46M | 20.45M | 20.41M | 20.36M | 20.36M | 20.21M | 20.69M | 23.04M | 20.64M |
| EBIT | 184.52M | 254.4M | 217.92M | 202.44M | 141.53M | 182.75M | 169.67M | 117.23M | 95.54M | 106.39M | 106.27M | 97.65M |
| Net Interest Income | -4.19M | -4.91M | 1.04M | 2.5M | -4.53M | -4.54M | -4.52M | -4.52M | -4.51M | -5.22M | -4.5M | -4.49M |
| Interest Income | 1.32M | 0 | 5.33M | 6.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.51M | 4.91M | 4.3M | 4.39M | 4.53M | 4.54M | 4.52M | 4.52M | 4.51M | 5.22M | 4.5M | 4.49M |
| Other Income/Expense | -4.19M | -355.25M | 1.04M | 2.5M | 2.29M | 2.71M | 1.95M | 508K | 486K | 140K | 13.48M | -1.3M |
| Pretax Income | 180.33M | -100.85M | 218.96M | 204.94M | 143.83M | 178.21M | 165.15M | 117.74M | 96.03M | 101.17M | 101.76M | 93.16M |
| Pretax Margin % | 47.87% | -22.32% | 61.81% | 62.92% | 54.3% | 59.8% | 56.93% | 50.89% | 49.02% | 43.98% | 47.1% | 42.14% |
| Income Tax | 30.28M | 40.74M | 43.73M | 39.78M | 25.73M | 41.2M | 28.14M | 24.5M | 19.2M | 15.79M | 19.92M | 18.4M |
| Effective Tax Rate % | 16.79% | -40.4% | 19.97% | 19.41% | 17.89% | 23.12% | 17.04% | 20.81% | 20% | 15.6% | 19.58% | 19.75% |
| Net Income | 150.05M | -141.59M | 175.22M | 165.16M | 118.09M | 137.01M | 137.01M | 93.25M | 76.82M | 85.39M | 81.84M | 74.75M |
| Net Margin % | 39.83% | -31.34% | 49.46% | 50.71% | 44.59% | 45.98% | 47.23% | 40.3% | 39.22% | 37.12% | 37.88% | 33.82% |
| Net Income Growth % | 27.06% | -203.34% | 27.89% | 77.12% | 53.72% | 60.46% | 67.42% | 24.74% | 93.92% | 47.98% | 32.78% | 229.53% |
| Net Income (Continuing) | 150.05M | -141.59M | 175.22M | 165.16M | 118.09M | 137.01M | 137.01M | 93.25M | 76.82M | 85.39M | 81.84M | 74.75M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.22 | -1.20 | 1.43 | 1.33 | 0.93 | 1.06 | 1.05 | 0.72 | 0.60 | 0.65 | 0.61 | 0.56 |
| EPS Growth % | 31.18% | -213.21% | 36.19% | 84.72% | 55% | 63.08% | 72.13% | 28.57% | 106.9% | 54.76% | 38.64% | 250% |
| EPS (Basic) | 1.27 | -1.20 | 1.49 | 1.36 | 0.96 | 1.08 | 1.08 | 0.73 | 0.61 | 0.66 | 0.62 | 0.57 |
| Diluted Shares Outstanding | 122.88M | 117.67M | 122.33M | 124.16M | 126.64M | 129.42M | 130.13M | 129.22M | 128.89M | 131.03M | 134.08M | 133.54M |
| Basic Shares Outstanding | 118.14M | 117.67M | 117.22M | 121.34M | 123.22M | 126.41M | 126.85M | 127.12M | 126.94M | 129.05M | 131.97M | 131.73M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |